Brought to you by 
Misonix buys Solsys Medical for $97mm plus net debt; acquisition closes at $109mm
11 Sep 2020
Executive Summary
Misonix Inc. penned a definitive agreement to acquire privately held regenerative medicine firm Solsys Medical LLC in an all-stock transaction. Misonix will issue approximately 5.7mm new shares valued at $97mm (based on the market average), and will also assume $20mm in outstanding secured debt.
Deal Industry
- Medical Devices
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Misonix buys Solsys Medical for $97mm plus net debt; acquisition closes at $109mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice